This page shows the latest care news and features for those working in and with pharma, biotech and healthcare.
I usually wouldn’t care about pop culture awards – this time is different. ... Or worse yet, have heard of it and don’t care about it.
Bamlanivimab-treated care home residents and staff had a significant reduction in COVID-19 risk. ... Currently, residents and staff in care homes have been identified as a top priority group to receive COVID-19 vaccines.
Care Excellence (NICE).
placebo. “Since its US approval, Esbriet has become a standard of care for people living with idiopathic pulmonary fibrosis,” said Levi Garraway, chief medical officer and head of Global Product Development,
In the final day 29 results, remdesivir plus standard-of-care treatment were able to cut the time to clinical recovery by five days compared to placebo, with a median time ... Another study, SIMPLE-Moderate, showed statistically improved clinical
Strategy. The Department of Health and Social Care (DHSC) has announced that a total of 4.06 million people have received the first dose of a COVID-19 vaccine, as of ... That figure includes more than half of those aged 80 and over and more than half of
More from news
Approximately 42 fully matching, plus 2,738 partially matching documents found.
Amgen developed a portfolio of supportive cancer care drugs including Epogen, Neupogen and Aranesp, and Endo Pharmaceuticals developed a pipeline of pain products that includes Lidoderm, Percocet and Opana. ... Novartis created Novartis Oncology in 2016
NIAID’s Adaptive COVID-19 Treatment Trial (ACTT-1) showed that remdesivir Standard of Care (SOC) significantly shortened time to recovery, provided greater clinical improvement and also reduced disease progression compared ... a 10-day dosing regimen
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care. ... Driving an evolution in care. There is a very real and unmet need to improve the standard of care for people with CKD.
AI-enabled solutions will also enhance patient engagement in their own care, giving them the knowledge that they need to take their health into their own hands. ... Streamlining the delivery of healthcare. The growing use of big data and AI will also
Exploring the gap. To explore this gap, we decided to study the uptake of five different innovative medical technologies across multiple secondary care centres. ... This adoption process often takes place in a separate clinical sphere, such as when one
More from intelligence
Approximately 5 fully matching, plus 509 partially matching documents found.
Since its first approval in 2014 for the treatment of advanced melanoma with BRAF mutations, Keytruda has become a blockbuster immunotherapy as well as introducing a new standard-of-care for
The National Institute for Health and Care Excellence (NICE) has appointed Gillian Leng (pictured above), CBE, as its new chief executive, who assumes the role from long-serving chief Sir Andrew ... Leng has been deputy chief executive at NICE since 2007
As a managing director, Springham will head up Four Health Media – the group's health care professionals media planning and buying specialists. ... In addition, Smith has an in-depth knowledge of the nursing and primary care market, after spending
The group offers first-hand clinical experience to both colleagues and clients, adding value and insight into what resonates with health care professionals and patients.
Starting off in Abbott’s Diabetes Care business, Ford has since served in many leadership roles within the company, including in the Nutrition and Medical Device businesses. ... Jude Medical – Abbott’s largest acquisition. He also led Abbott’s
More from appointments
Approximately 3 fully matching, plus 188 partially matching documents found.
Non-urgent care has been paused, as doctors and nurses have been redeployed in the effort against the pandemic. ... For example, all CAR-T cell therapies were paused as intensive care unit beds were needed to help COVID-19 patients recover.
With reduced access to primary care, limited capacity in hospitals, and clinical trial participants unable to visit investigator sites, it’s taken countless innovative changes in procedures to enable hospitals, clinics,
HCPs had to adjust how they delivered care (often though telemedicine) and address the many wider needs such as access to medicines.
We recognise that only true engagement can facilitate change and we use our combination of scientific, creative and technical expertise to stimulate optimal participation of all those in the care pathway. .
On 20th February, we attended ‘The Unusual Suspects: Rare Diseases in Everyday Medical Care” at the Royal Society of Medicine, hosted by Medics 4 Rare Diseases (M4RD). . ... We recognise that only true engagement can facilitate change and we
More from PMHub
Approximately 34 fully matching, plus 547 partially matching documents found.
Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...